HEADER HYDROLASE 25-APR-03 1P5C TITLE CIRCULAR PERMUTATION OF HELIX A IN T4 LYSOZYME COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOZYME; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: LYSIS PROTEIN, MURAMIDASE, ENDOLYSIN; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_TAXID: 10665; SOURCE 4 GENE: GENE E; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: RR1; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHS1403 KEYWDS CIRCULAR PERMUTATION, PROTEIN DESIGN, CONTEXT DEPENDENT FOLDING, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SAGERMANN,L.GAY,W.A.BAASE,B.W.MATTHEWS REVDAT 6 16-AUG-23 1P5C 1 REMARK REVDAT 5 27-OCT-21 1P5C 1 SEQADV REVDAT 4 14-AUG-19 1P5C 1 REMARK REVDAT 3 24-JUL-19 1P5C 1 REMARK REVDAT 2 24-FEB-09 1P5C 1 VERSN REVDAT 1 04-MAY-04 1P5C 0 JRNL AUTH M.SAGERMANN,W.A.BAASE,B.H.MOOERS,L.GAY,B.W.MATTHEWS JRNL TITL RELOCATION OR DUPLICATION OF THE HELIX A SEQUENCE OF T4 JRNL TITL 2 LYSOZYME CAUSES ONLY MODEST CHANGES IN STRUCTURE BUT CAN JRNL TITL 3 INCREASE OR DECREASE THE RATE OF FOLDING. JRNL REF BIOCHEMISTRY V. 43 1296 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 14756565 JRNL DOI 10.1021/BI035702Q REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.SAGERMANN,B.W.MATTHEWS REMARK 1 TITL CRYSTAL STRUCTURES OF A T4-LYSOZYME DUPLICATION-EXTENSION REMARK 1 TITL 2 MUTANT DEMONSTRATES THAT THE HIGHLY CONSERVED BETA-SHEET REMARK 1 TITL 3 REGION HAS LOW INTRINSIC FOLDING PROPENSITY REMARK 1 REF J.MOL.BIOL. V. 316 931 2002 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2001.5376 REMARK 1 REFERENCE 2 REMARK 1 AUTH L.H.WEAVER,B.W.MATTHEWS REMARK 1 TITL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME REFINED AT 1.7 A REMARK 1 TITL 2 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 193 189 1987 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.SAGERMANN,W.A.BAASE,B.W.MATTHEWS REMARK 1 TITL STRUCTURAL CHARACTERIZATION OF AN ENGINEERED TANDEM REPEAT REMARK 1 TITL 2 CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN REMARK 1 TITL 3 FOLDING REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 96 6078 1999 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.96.11.6078 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 22881 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.310 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2324 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 23573 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 286 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 35.110 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.012 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 13.600; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : 1.700 ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : ENGH & HUBER REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AMINO TERMINAL METHIONINE RESIDUE NOT REMARK 3 VISIBLE IN DENSITY. REMARK 4 REMARK 4 1P5C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-03. REMARK 100 THE DEPOSITION ID IS D_1000019026. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 170 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : SINGLE SI CRYSTAL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22893 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07600 REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.08800 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2LZM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 3400, 50MM PHOSPHATE BUFFER, REMARK 280 5% ISOPROPANOL, PH 7.1, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.88150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: PROTEIN IS A MONOMER IN SOLUTION. THE ASYMMETRIC UNIT REMARK 300 CONTAINS 4 MOLECULES. THE REFINEMENT WAS PERFORMED IN THE ABSENCE REMARK 300 OF NCS OPERATORS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 12 REMARK 465 MET B 12 REMARK 465 MET C 12 REMARK 465 MET D 12 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR A 18 O HOH A 260 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO C 143 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 21 -5.55 -57.49 REMARK 500 ASN A 55 26.15 49.47 REMARK 500 LYS A 135 56.38 -102.31 REMARK 500 PRO B 37 49.95 -78.63 REMARK 500 ARG B 125 59.97 -96.23 REMARK 500 LYS B 135 62.54 -109.52 REMARK 500 LYS D 135 43.10 -91.45 REMARK 500 MET D 168 13.55 -142.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JTM RELATED DB: PDB REMARK 900 DUPLICATION EXTENSION OF THE B-SHEET SEQUENCE OF T4 LYSOZYME REMARK 900 RELATED ID: 1P56 RELATED DB: PDB REMARK 900 DUPLICATION-EXTENSION OF HELIX A OF T4 LYSOZYME REMARK 900 RELATED ID: 262L RELATED DB: PDB REMARK 900 HELIX B TANDEM REPEAT REMARK 900 RELATED ID: 1OYU RELATED DB: PDB REMARK 900 HELIX B TANDEM REPEAT, ALTERNATIVE CONFORMATION REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE LEU 164 WAS DELETED AND SEQUENCE SGGAMNIFEMLRIDE REMARK 999 WAS APPENDED TO THE C-TERMINUS DBREF 1P5C A 12 178 UNP P00720 LYS_BPT4 12 163 DBREF 1P5C B 12 178 UNP P00720 LYS_BPT4 12 163 DBREF 1P5C C 12 178 UNP P00720 LYS_BPT4 12 163 DBREF 1P5C D 12 178 UNP P00720 LYS_BPT4 12 163 SEQADV 1P5C MET A 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR A 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA A 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER A 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY A 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY A 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA A 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET A 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN A 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE A 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE A 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU A 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET A 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG A 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE A 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP A 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU A 178 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET B 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR B 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA B 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER B 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY B 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY B 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA B 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET B 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN B 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE B 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE B 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU B 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET B 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG B 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE B 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP B 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU B 178 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET C 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR C 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA C 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER C 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY C 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY C 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA C 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET C 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN C 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE C 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE C 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU C 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET C 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG C 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE C 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP C 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU C 178 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET D 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR D 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA D 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER D 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY D 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY D 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA D 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET D 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN D 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE D 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE D 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU D 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET D 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG D 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE D 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP D 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU D 178 UNP P00720 SEE REMARK 999 SEQRES 1 A 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 A 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 A 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 A 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 A 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 A 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 A 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 A 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 A 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 A 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 A 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 A 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 A 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 1 B 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 B 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 B 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 B 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 B 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 B 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 B 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 B 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 B 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 B 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 B 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 B 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 B 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 1 C 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 C 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 C 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 C 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 C 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 C 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 C 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 C 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 C 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 C 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 C 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 C 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 C 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 1 D 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 D 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 D 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 D 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 D 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 D 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 D 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 D 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 D 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 D 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 D 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 D 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 D 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU FORMUL 5 HOH *286(H2 O) HELIX 1 1 SER A 38 GLY A 51 1 14 HELIX 2 2 THR A 59 ASN A 81 1 23 HELIX 3 3 LYS A 83 LEU A 91 1 9 HELIX 4 4 ASP A 92 GLY A 107 1 16 HELIX 5 5 GLY A 107 GLY A 113 1 7 HELIX 6 6 PHE A 114 GLN A 123 1 10 HELIX 7 7 ARG A 125 ALA A 134 1 10 HELIX 8 8 SER A 136 THR A 142 1 7 HELIX 9 9 THR A 142 GLY A 156 1 15 HELIX 10 10 TRP A 158 LYS A 162 5 5 HELIX 11 11 ASN A 169 GLU A 178 1 10 HELIX 12 12 SER B 38 GLY B 51 1 14 HELIX 13 13 THR B 59 ARG B 80 1 22 HELIX 14 14 LYS B 83 LEU B 91 1 9 HELIX 15 15 ASP B 92 GLY B 107 1 16 HELIX 16 16 GLY B 107 GLY B 113 1 7 HELIX 17 17 PHE B 114 GLN B 123 1 10 HELIX 18 18 ARG B 125 ALA B 134 1 10 HELIX 19 19 SER B 136 THR B 142 1 7 HELIX 20 20 THR B 142 GLY B 156 1 15 HELIX 21 21 TRP B 158 GLY B 165 5 8 HELIX 22 22 ASN B 169 GLU B 178 1 10 HELIX 23 23 SER C 38 GLY C 51 1 14 HELIX 24 24 THR C 59 ARG C 80 1 22 HELIX 25 25 LYS C 83 LEU C 91 1 9 HELIX 26 26 ASP C 92 GLY C 107 1 16 HELIX 27 27 GLY C 107 GLY C 113 1 7 HELIX 28 28 PHE C 114 GLN C 123 1 10 HELIX 29 29 ARG C 125 ALA C 134 1 10 HELIX 30 30 SER C 136 THR C 142 1 7 HELIX 31 31 THR C 142 GLY C 156 1 15 HELIX 32 32 TRP C 158 GLY C 165 5 8 HELIX 33 33 ASN C 169 GLU C 178 1 10 HELIX 34 34 SER D 38 GLY D 51 1 14 HELIX 35 35 THR D 59 ARG D 80 1 22 HELIX 36 36 LYS D 83 LEU D 91 1 9 HELIX 37 37 ASP D 92 GLY D 107 1 16 HELIX 38 38 GLY D 107 GLY D 113 1 7 HELIX 39 39 PHE D 114 GLN D 123 1 10 HELIX 40 40 ARG D 125 LYS D 135 1 11 HELIX 41 41 SER D 136 THR D 142 1 7 HELIX 42 42 THR D 142 GLY D 156 1 15 HELIX 43 43 TRP D 158 GLY D 165 5 8 HELIX 44 44 ASN D 169 GLU D 178 1 10 SHEET 1 A 3 ARG A 14 LYS A 19 0 SHEET 2 A 3 TYR A 25 GLY A 28 -1 O THR A 26 N TYR A 18 SHEET 3 A 3 HIS A 31 THR A 34 -1 O LEU A 33 N TYR A 25 SHEET 1 B 3 TYR B 18 LYS B 19 0 SHEET 2 B 3 TYR B 25 ILE B 27 -1 O THR B 26 N TYR B 18 SHEET 3 B 3 HIS B 31 THR B 34 -1 O HIS B 31 N ILE B 27 SHEET 1 C 3 ARG C 14 LYS C 19 0 SHEET 2 C 3 TYR C 25 GLY C 28 -1 O THR C 26 N TYR C 18 SHEET 3 C 3 HIS C 31 THR C 34 -1 O LEU C 33 N TYR C 25 SHEET 1 D 3 ARG D 14 LYS D 19 0 SHEET 2 D 3 TYR D 25 GLY D 28 -1 O THR D 26 N TYR D 18 SHEET 3 D 3 HIS D 31 THR D 34 -1 O LEU D 33 N TYR D 25 CRYST1 53.758 67.763 94.057 90.00 92.58 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018602 0.000000 0.000838 0.00000 SCALE2 0.000000 0.014757 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010643 0.00000